Tuesday, October 17, 2017 10:15 PM ET
Insider Makes Significant Stock buy in BioTime (BTX) Shares Extends the Trend of Last 90 Days
Significant insider purchase activity was revealed in BioTime shares in a form 4 document filed with the SEC today, showing — Broadwood Partners Lp, 10% Owner and Director — bought 2,692,307 shares in the company having a net market value of approximately $6,999,998. There have been 7 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the acquisition of 181,396 company shares and the disposition of 150,000 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 2,723,703 shares and have averaged 377,963 shares per transaction over this time period.
Compared to its peers over the last 90 days, insider buy/sell trading at BioTime is greater than the 264-company peer group average. Bio Therapeutic Drugs peer group saw 312 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for BioTime insiders was also higher. Within the peer group there were 8,464,476 shares purchased and 12,452,450 shares sold with company insiders having sold 12,782 shares on average.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to evaluate and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.